These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 32884985)

  • 1. Advances in the early diagnosis of hepatocellular carcinoma.
    Wang W; Wei C
    Genes Dis; 2020 Sep; 7(3):308-319. PubMed ID: 32884985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review.
    Sharma KK; Moshin M; Mittal P; Ali Z; Fatma N; Upadhyay P; Gupta R; Verma A; Kumar G
    Curr Pharm Des; 2024 May; ():. PubMed ID: 38797901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.
    Wang T; Zhang KH
    Front Oncol; 2020; 10():1316. PubMed ID: 32923383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.
    Jia Z; Wang L; Liu C; Yu Z; Chai L; Zhao M
    Contemp Oncol (Pozn); 2014; 18(3):192-6. PubMed ID: 25520580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
    Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
    Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.
    Guo W; Tan HY; Wang N; Wang X; Feng Y
    Cancer Manag Res; 2018; 10():715-734. PubMed ID: 29692630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
    Kudo M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
    Choi J; Kim GA; Han S; Lee W; Chun S; Lim YS
    Hepatology; 2019 May; 69(5):1983-1994. PubMed ID: 30153338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating biomarkers for early detection of hepatocellular carcinoma.
    Beudeker BJB; Boonstra A
    Therap Adv Gastroenterol; 2020; 13():1756284820931734. PubMed ID: 32647536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.